Request for Covid-19 Impact Assessment of this Report

Healthcare

COVID-19 Impact on Global Transdermal Skin Patch, Market Insights and Forecast to 2026

  • BMR3903743
  • 118 Pages
  • June 2020
  • Healthcare
Download Sample    Get Discount   
 
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Transdermal Skin Patch market in 2020.

COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.

The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

This report also analyses the impact of Coronavirus COVID-19 on the Transdermal Skin Patch industry.

Based on our recent survey, we have several different scenarios about the Transdermal Skin Patch YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Transdermal Skin Patch will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Transdermal Skin Patch market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Transdermal Skin Patch market in terms of both revenue and volume.

Players, stakeholders, and other participants in the global Transdermal Skin Patch market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.

Sales and Pricing Analyses

Readers are provided with deeper sales analysis and pricing analysis for the global Transdermal Skin Patch market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.

In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.

Regional and Country-level Analysis

The report offers an exhaustive geographical analysis of the global Transdermal Skin Patch market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.

Competition Analysis

In the competitive analysis section of the report, leading as well as prominent players of the global Transdermal Skin Patch market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Transdermal Skin Patch market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Transdermal Skin Patch market.

The following manufacturers are covered in this report:

Hisamitsu Pharmaceutical

Novartis

Johnson & Johnson

Teikoku Pharma

Mylan

Actavis

Mundipharma

Henan Lingrui Pharmaceutical

Changzhou Siyao

Rfl Pharmaceutical

Luye Pharma Group Ltd.

Purdue Pharma L.P.

Teva Pharmaceutical Industries Ltd.

Transdermal Skin Patch Breakdown Data by Type

Fentanyl Transdermal Skin Patch

Nicotine Transdermal Skin Patch

Clonidine Transdermal Skin Patch

Buprenorphine Transdermal Skin Patch

Transdermal Skin Patch Breakdown Data by Application

Relieve Severe Pain

Stop Smoking Cigarettes

Treat An Overactive Bladder

Others

1 Study Coverage

1.1 Transdermal Skin Patch Product Introduction

1.2 Market Segments

1.3 Key Transdermal Skin Patch Manufacturers Covered: Ranking by Revenue

1.4 Market by Type

1.4.1 Global Transdermal Skin Patch Market Size Growth Rate by Type

1.4.2 Fentanyl Transdermal Skin Patch

1.4.3 Nicotine Transdermal Skin Patch

1.4.4 Clonidine Transdermal Skin Patch

1.4.5 Buprenorphine Transdermal Skin Patch

1.5 Market by Application

1.5.1 Global Transdermal Skin Patch Market Size Growth Rate by Application

1.5.2 Relieve Severe Pain

1.5.3 Stop Smoking Cigarettes

1.5.4 Treat An Overactive Bladder

1.5.5 Others

1.6 Coronavirus Disease 2019 (Covid-19): Transdermal Skin Patch Industry Impact

1.6.1 How the Covid-19 is Affecting the Transdermal Skin Patch Industry

1.6.1.1 Transdermal Skin Patch Business Impact Assessment - Covid-19

1.6.1.2 Supply Chain Challenges

1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products

1.6.2 Market Trends and Transdermal Skin Patch Potential Opportunities in the COVID-19 Landscape

1.6.3 Measures / Proposal against Covid-19

1.6.3.1 Government Measures to Combat Covid-19 Impact

1.6.3.2 Proposal for Transdermal Skin Patch Players to Combat Covid-19 Impact

1.7 Study Objectives

1.8 Years Considered

2 Executive Summary

2.1 Global Transdermal Skin Patch Market Size Estimates and Forecasts

2.1.1 Global Transdermal Skin Patch Revenue 2015-2026

2.1.2 Global Transdermal Skin Patch Sales 2015-2026

2.2 Transdermal Skin Patch Market Size by Region: 2020 Versus 2026

2.2.1 Global Transdermal Skin Patch Retrospective Market Scenario in Sales by Region: 2015-2020

2.2.2 Global Transdermal Skin Patch Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Transdermal Skin Patch Competitor Landscape by Players

3.1 Transdermal Skin Patch Sales by Manufacturers

3.1.1 Transdermal Skin Patch Sales by Manufacturers (2015-2020)

3.1.2 Transdermal Skin Patch Sales Market Share by Manufacturers (2015-2020)

3.2 Transdermal Skin Patch Revenue by Manufacturers

3.2.1 Transdermal Skin Patch Revenue by Manufacturers (2015-2020)

3.2.2 Transdermal Skin Patch Revenue Share by Manufacturers (2015-2020)

3.2.3 Global Transdermal Skin Patch Market Concentration Ratio (CR5 and HHI) (2015-2020)

3.2.4 Global Top 10 and Top 5 Companies by Transdermal Skin Patch Revenue in 2019

3.2.5 Global Transdermal Skin Patch Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

3.3 Transdermal Skin Patch Price by Manufacturers

3.4 Transdermal Skin Patch Manufacturing Base Distribution, Product Types

3.4.1 Transdermal Skin Patch Manufacturers Manufacturing Base Distribution, Headquarters

3.4.2 Manufacturers Transdermal Skin Patch Product Type

3.4.3 Date of International Manufacturers Enter into Transdermal Skin Patch Market

3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

4.1 Global Transdermal Skin Patch Market Size by Type (2015-2020)

4.1.1 Global Transdermal Skin Patch Sales by Type (2015-2020)

4.1.2 Global Transdermal Skin Patch Revenue by Type (2015-2020)

4.1.3 Transdermal Skin Patch Average Selling Price (ASP) by Type (2015-2026)

4.2 Global Transdermal Skin Patch Market Size Forecast by Type (2021-2026)

4.2.1 Global Transdermal Skin Patch Sales Forecast by Type (2021-2026)

4.2.2 Global Transdermal Skin Patch Revenue Forecast by Type (2021-2026)

4.2.3 Transdermal Skin Patch Average Selling Price (ASP) Forecast by Type (2021-2026)

4.3 Global Transdermal Skin Patch Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Breakdown Data by Application (2015-2026)

5.1 Global Transdermal Skin Patch Market Size by Application (2015-2020)

5.1.1 Global Transdermal Skin Patch Sales by Application (2015-2020)

5.1.2 Global Transdermal Skin Patch Revenue by Application (2015-2020)

5.1.3 Transdermal Skin Patch Price by Application (2015-2020)

5.2 Transdermal Skin Patch Market Size Forecast by Application (2021-2026)

5.2.1 Global Transdermal Skin Patch Sales Forecast by Application (2021-2026)

5.2.2 Global Transdermal Skin Patch Revenue Forecast by Application (2021-2026)

5.2.3 Global Transdermal Skin Patch Price Forecast by Application (2021-2026)

6 North America

6.1 North America Transdermal Skin Patch by Country

6.1.1 North America Transdermal Skin Patch Sales by Country

6.1.2 North America Transdermal Skin Patch Revenue by Country

6.1.3 U.S.

6.1.4 Canada

6.2 North America Transdermal Skin Patch Market Facts & Figures by Type

6.3 North America Transdermal Skin Patch Market Facts & Figures by Application

7 Europe

7.1 Europe Transdermal Skin Patch by Country

7.1.1 Europe Transdermal Skin Patch Sales by Country

7.1.2 Europe Transdermal Skin Patch Revenue by Country

7.1.3 Germany

7.1.4 France

7.1.5 U.K.

7.1.6 Italy

7.1.7 Russia

7.2 Europe Transdermal Skin Patch Market Facts & Figures by Type

7.3 Europe Transdermal Skin Patch Market Facts & Figures by Application

8 Asia Pacific

8.1 Asia Pacific Transdermal Skin Patch by Region

8.1.1 Asia Pacific Transdermal Skin Patch Sales by Region

8.1.2 Asia Pacific Transdermal Skin Patch Revenue by Region

8.1.3 China

8.1.4 Japan

8.1.5 South Korea

8.1.6 India

8.1.7 Australia

8.1.8 Taiwan

8.1.9 Indonesia

8.1.10 Thailand

8.1.11 Malaysia

8.1.12 Philippines

8.1.13 Vietnam

8.2 Asia Pacific Transdermal Skin Patch Market Facts & Figures by Type

8.3 Asia Pacific Transdermal Skin Patch Market Facts & Figures by Application

9 Latin America

9.1 Latin America Transdermal Skin Patch by Country

9.1.1 Latin America Transdermal Skin Patch Sales by Country

9.1.2 Latin America Transdermal Skin Patch Revenue by Country

9.1.3 Mexico

9.1.4 Brazil

9.1.5 Argentina

9.2 Central & South America Transdermal Skin Patch Market Facts & Figures by Type

9.3 Central & South America Transdermal Skin Patch Market Facts & Figures by Application

10 Middle East and Africa

10.1 Middle East and Africa Transdermal Skin Patch by Country

10.1.1 Middle East and Africa Transdermal Skin Patch Sales by Country

10.1.2 Middle East and Africa Transdermal Skin Patch Revenue by Country

10.1.3 Turkey

10.1.4 Saudi Arabia

10.1.5 U.A.E

10.2 Middle East and Africa Transdermal Skin Patch Market Facts & Figures by Type

10.3 Middle East and Africa Transdermal Skin Patch Market Facts & Figures by Application

11 Company Profiles

11.1 Hisamitsu Pharmaceutical

11.1.1 Hisamitsu Pharmaceutical Corporation Information

11.1.2 Hisamitsu Pharmaceutical Description, Business Overview and Total Revenue

11.1.3 Hisamitsu Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)

11.1.4 Hisamitsu Pharmaceutical Transdermal Skin Patch Products Offered

11.1.5 Hisamitsu Pharmaceutical Recent Development

11.2 Novartis

11.2.1 Novartis Corporation Information

11.2.2 Novartis Description, Business Overview and Total Revenue

11.2.3 Novartis Sales, Revenue and Gross Margin (2015-2020)

11.2.4 Novartis Transdermal Skin Patch Products Offered

11.2.5 Novartis Recent Development

11.3 Johnson & Johnson

11.3.1 Johnson & Johnson Corporation Information

11.3.2 Johnson & Johnson Description, Business Overview and Total Revenue

11.3.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)

11.3.4 Johnson & Johnson Transdermal Skin Patch Products Offered

11.3.5 Johnson & Johnson Recent Development

11.4 Teikoku Pharma

11.4.1 Teikoku Pharma Corporation Information

11.4.2 Teikoku Pharma Description, Business Overview and Total Revenue

11.4.3 Teikoku Pharma Sales, Revenue and Gross Margin (2015-2020)

11.4.4 Teikoku Pharma Transdermal Skin Patch Products Offered

11.4.5 Teikoku Pharma Recent Development

11.5 Mylan

11.5.1 Mylan Corporation Information

11.5.2 Mylan Description, Business Overview and Total Revenue

11.5.3 Mylan Sales, Revenue and Gross Margin (2015-2020)

11.5.4 Mylan Transdermal Skin Patch Products Offered

11.5.5 Mylan Recent Development

11.6 Actavis

11.6.1 Actavis Corporation Information

11.6.2 Actavis Description, Business Overview and Total Revenue

11.6.3 Actavis Sales, Revenue and Gross Margin (2015-2020)

11.6.4 Actavis Transdermal Skin Patch Products Offered

11.6.5 Actavis Recent Development

11.7 Mundipharma

11.7.1 Mundipharma Corporation Information

11.7.2 Mundipharma Description, Business Overview and Total Revenue

11.7.3 Mundipharma Sales, Revenue and Gross Margin (2015-2020)

11.7.4 Mundipharma Transdermal Skin Patch Products Offered

11.7.5 Mundipharma Recent Development

11.8 Henan Lingrui Pharmaceutical

11.8.1 Henan Lingrui Pharmaceutical Corporation Information

11.8.2 Henan Lingrui Pharmaceutical Description, Business Overview and Total Revenue

11.8.3 Henan Lingrui Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)

11.8.4 Henan Lingrui Pharmaceutical Transdermal Skin Patch Products Offered

11.8.5 Henan Lingrui Pharmaceutical Recent Development

11.9 Changzhou Siyao

11.9.1 Changzhou Siyao Corporation Information

11.9.2 Changzhou Siyao Description, Business Overview and Total Revenue

11.9.3 Changzhou Siyao Sales, Revenue and Gross Margin (2015-2020)

11.9.4 Changzhou Siyao Transdermal Skin Patch Products Offered

11.9.5 Changzhou Siyao Recent Development

11.10 Rfl Pharmaceutical

11.10.1 Rfl Pharmaceutical Corporation Information

11.10.2 Rfl Pharmaceutical Description, Business Overview and Total Revenue

11.10.3 Rfl Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)

11.10.4 Rfl Pharmaceutical Transdermal Skin Patch Products Offered

11.10.5 Rfl Pharmaceutical Recent Development

11.1 Hisamitsu Pharmaceutical

11.1.1 Hisamitsu Pharmaceutical Corporation Information

11.1.2 Hisamitsu Pharmaceutical Description, Business Overview and Total Revenue

11.1.3 Hisamitsu Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)

11.1.4 Hisamitsu Pharmaceutical Transdermal Skin Patch Products Offered

11.1.5 Hisamitsu Pharmaceutical Recent Development

11.12 Purdue Pharma L.P.

11.12.1 Purdue Pharma L.P. Corporation Information

11.12.2 Purdue Pharma L.P. Description, Business Overview and Total Revenue

11.12.3 Purdue Pharma L.P. Sales, Revenue and Gross Margin (2015-2020)

11.12.4 Purdue Pharma L.P. Products Offered

11.12.5 Purdue Pharma L.P. Recent Development

11.13 Teva Pharmaceutical Industries Ltd.

11.13.1 Teva Pharmaceutical Industries Ltd. Corporation Information

11.13.2 Teva Pharmaceutical Industries Ltd. Description, Business Overview and Total Revenue

11.13.3 Teva Pharmaceutical Industries Ltd. Sales, Revenue and Gross Margin (2015-2020)

11.13.4 Teva Pharmaceutical Industries Ltd. Products Offered

11.13.5 Teva Pharmaceutical Industries Ltd. Recent Development

12 Future Forecast by Regions (Countries) (2021-2026)

12.1 Transdermal Skin Patch Market Estimates and Projections by Region

12.1.1 Global Transdermal Skin Patch Sales Forecast by Regions 2021-2026

12.1.2 Global Transdermal Skin Patch Revenue Forecast by Regions 2021-2026

12.2 North America Transdermal Skin Patch Market Size Forecast (2021-2026)

12.2.1 North America: Transdermal Skin Patch Sales Forecast (2021-2026)

12.2.2 North America: Transdermal Skin Patch Revenue Forecast (2021-2026)

12.2.3 North America: Transdermal Skin Patch Market Size Forecast by Country (2021-2026)

12.3 Europe Transdermal Skin Patch Market Size Forecast (2021-2026)

12.3.1 Europe: Transdermal Skin Patch Sales Forecast (2021-2026)

12.3.2 Europe: Transdermal Skin Patch Revenue Forecast (2021-2026)

12.3.3 Europe: Transdermal Skin Patch Market Size Forecast by Country (2021-2026)

12.4 Asia Pacific Transdermal Skin Patch Market Size Forecast (2021-2026)

12.4.1 Asia Pacific: Transdermal Skin Patch Sales Forecast (2021-2026)

12.4.2 Asia Pacific: Transdermal Skin Patch Revenue Forecast (2021-2026)

12.4.3 Asia Pacific: Transdermal Skin Patch Market Size Forecast by Region (2021-2026)

12.5 Latin America Transdermal Skin Patch Market Size Forecast (2021-2026)

12.5.1 Latin America: Transdermal Skin Patch Sales Forecast (2021-2026)

12.5.2 Latin America: Transdermal Skin Patch Revenue Forecast (2021-2026)

12.5.3 Latin America: Transdermal Skin Patch Market Size Forecast by Country (2021-2026)

12.6 Middle East and Africa Transdermal Skin Patch Market Size Forecast (2021-2026)

12.6.1 Middle East and Africa: Transdermal Skin Patch Sales Forecast (2021-2026)

12.6.2 Middle East and Africa: Transdermal Skin Patch Revenue Forecast (2021-2026)

12.6.3 Middle East and Africa: Transdermal Skin Patch Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

13.1 Market Opportunities and Drivers

13.2 Market Challenges

13.3 Market Risks/Restraints

13.4 Porter’s Five Forces Analysis

13.5 Primary Interviews with Key Transdermal Skin Patch Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

14.1 Value Chain Analysis

14.2 Transdermal Skin Patch Customers

14.3 Sales Channels Analysis

14.3.1 Sales Channels

14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

16.1 Research Methodology

16.1.1 Methodology/Research Approach

16.1.2 Data Source

16.2 Author Details

List of Tables

Table 1. Transdermal Skin Patch Market Segments

Table 2. Ranking of Global Top Transdermal Skin Patch Manufacturers by Revenue (US$ Million) in 2019

Table 3. Global Transdermal Skin Patch Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)

Table 4. Major Manufacturers of Fentanyl Transdermal Skin Patch

Table 5. Major Manufacturers of Nicotine Transdermal Skin Patch

Table 6. Major Manufacturers of Clonidine Transdermal Skin Patch

Table 7. Major Manufacturers of Buprenorphine Transdermal Skin Patch

Table 8. COVID-19 Impact Global Market: (Four Transdermal Skin Patch Market Size Forecast Scenarios)

Table 9. Opportunities and Trends for Transdermal Skin Patch Players in the COVID-19 Landscape

Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis

Table 11. Key Regions/Countries Measures against Covid-19 Impact

Table 12. Proposal for Transdermal Skin Patch Players to Combat Covid-19 Impact

Table 13. Global Transdermal Skin Patch Market Size Growth Rate by Application 2020-2026 (K Units)

Table 14. Global Transdermal Skin Patch Market Size by Region (K Units) & (US$ Million): 2020 VS 2026

Table 15. Global Transdermal Skin Patch Sales by Regions 2015-2020 (K Units)

Table 16. Global Transdermal Skin Patch Sales Market Share by Regions (2015-2020)

Table 17. Global Transdermal Skin Patch Revenue by Regions 2015-2020 (US$ Million)

Table 18. Global Transdermal Skin Patch Sales by Manufacturers (2015-2020) (K Units)

Table 19. Global Transdermal Skin Patch Sales Share by Manufacturers (2015-2020)

Table 20. Global Transdermal Skin Patch Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)

Table 21. Global Transdermal Skin Patch by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transdermal Skin Patch as of 2019)

Table 22. Transdermal Skin Patch Revenue by Manufacturers (2015-2020) (US$ Million)

Table 23. Transdermal Skin Patch Revenue Share by Manufacturers (2015-2020)

Table 24. Key Manufacturers Transdermal Skin Patch Price (2015-2020) (USD/Unit)

Table 25. Transdermal Skin Patch Manufacturers Manufacturing Base Distribution and Headquarters

Table 26. Manufacturers Transdermal Skin Patch Product Type

Table 27. Date of International Manufacturers Enter into Transdermal Skin Patch Market

Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 29. Global Transdermal Skin Patch Sales by Type (2015-2020) (K Units)

Table 30. Global Transdermal Skin Patch Sales Share by Type (2015-2020)

Table 31. Global Transdermal Skin Patch Revenue by Type (2015-2020) (US$ Million)

Table 32. Global Transdermal Skin Patch Revenue Share by Type (2015-2020)

Table 33. Transdermal Skin Patch Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)

Table 34. Global Transdermal Skin Patch Sales by Application (2015-2020) (K Units)

Table 35. Global Transdermal Skin Patch Sales Share by Application (2015-2020)

Table 36. North America Transdermal Skin Patch Sales by Country (2015-2020) (K Units)

Table 37. North America Transdermal Skin Patch Sales Market Share by Country (2015-2020)

Table 38. North America Transdermal Skin Patch Revenue by Country (2015-2020) (US$ Million)

Table 39. North America Transdermal Skin Patch Revenue Market Share by Country (2015-2020)

Table 40. North America Transdermal Skin Patch Sales by Type (2015-2020) (K Units)

Table 41. North America Transdermal Skin Patch Sales Market Share by Type (2015-2020)

Table 42. North America Transdermal Skin Patch Sales by Application (2015-2020) (K Units)

Table 43. North America Transdermal Skin Patch Sales Market Share by Application (2015-2020)

Table 44. Europe Transdermal Skin Patch Sales by Country (2015-2020) (K Units)

Table 45. Europe Transdermal Skin Patch Sales Market Share by Country (2015-2020)

Table 46. Europe Transdermal Skin Patch Revenue by Country (2015-2020) (US$ Million)

Table 47. Europe Transdermal Skin Patch Revenue Market Share by Country (2015-2020)

Table 48. Europe Transdermal Skin Patch Sales by Type (2015-2020) (K Units)

Table 49. Europe Transdermal Skin Patch Sales Market Share by Type (2015-2020)

Table 50. Europe Transdermal Skin Patch Sales by Application (2015-2020) (K Units)

Table 51. Europe Transdermal Skin Patch Sales Market Share by Application (2015-2020)

Table 52. Asia Pacific Transdermal Skin Patch Sales by Region (2015-2020) (K Units)

Table 53. Asia Pacific Transdermal Skin Patch Sales Market Share by Region (2015-2020)

Table 54. Asia Pacific Transdermal Skin Patch Revenue by Region (2015-2020) (US$ Million)

Table 55. Asia Pacific Transdermal Skin Patch Revenue Market Share by Region (2015-2020)

Table 56. Asia Pacific Transdermal Skin Patch Sales by Type (2015-2020) (K Units)

Table 57. Asia Pacific Transdermal Skin Patch Sales Market Share by Type (2015-2020)

Table 58. Asia Pacific Transdermal Skin Patch Sales by Application (2015-2020) (K Units)

Table 59. Asia Pacific Transdermal Skin Patch Sales Market Share by Application (2015-2020)

Table 60. Latin America Transdermal Skin Patch Sales by Country (2015-2020) (K Units)

Table 61. Latin America Transdermal Skin Patch Sales Market Share by Country (2015-2020)

Table 62. Latin Americaa Transdermal Skin Patch Revenue by Country (2015-2020) (US$ Million)

Table 63. Latin America Transdermal Skin Patch Revenue Market Share by Country (2015-2020)

Table 64. Latin America Transdermal Skin Patch Sales by Type (2015-2020) (K Units)

Table 65. Latin America Transdermal Skin Patch Sales Market Share by Type (2015-2020)

Table 66. Latin America Transdermal Skin Patch Sales by Application (2015-2020) (K Units)

Table 67. Latin America Transdermal Skin Patch Sales Market Share by Application (2015-2020)

Table 68. Middle East and Africa Transdermal Skin Patch Sales by Country (2015-2020) (K Units)

Table 69. Middle East and Africa Transdermal Skin Patch Sales Market Share by Country (2015-2020)

Table 70. Middle East and Africa Transdermal Skin Patch Revenue by Country (2015-2020) (US$ Million)

Table 71. Middle East and Africa Transdermal Skin Patch Revenue Market Share by Country (2015-2020)

Table 72. Middle East and Africa Transdermal Skin Patch Sales by Type (2015-2020) (K Units)

Table 73. Middle East and Africa Transdermal Skin Patch Sales Market Share by Type (2015-2020)

Table 74. Middle East and Africa Transdermal Skin Patch Sales by Application (2015-2020) (K Units)

Table 75. Middle East and Africa Transdermal Skin Patch Sales Market Share by Application (2015-2020)

Table 76. Hisamitsu Pharmaceutical Corporation Information

Table 77. Hisamitsu Pharmaceutical Description and Major Businesses

Table 78. Hisamitsu Pharmaceutical Transdermal Skin Patch Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 79. Hisamitsu Pharmaceutical Product

Table 80. Hisamitsu Pharmaceutical Recent Development

Table 81. Novartis Corporation Information

Table 82. Novartis Description and Major Businesses

Table 83. Novartis Transdermal Skin Patch Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 84. Novartis Product

Table 85. Novartis Recent Development

Table 86. Johnson & Johnson Corporation Information

Table 87. Johnson & Johnson Description and Major Businesses

Table 88. Johnson & Johnson Transdermal Skin Patch Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 89. Johnson & Johnson Product

Table 90. Johnson & Johnson Recent Development

Table 91. Teikoku Pharma Corporation Information

Table 92. Teikoku Pharma Description and Major Businesses

Table 93. Teikoku Pharma Transdermal Skin Patch Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 94. Teikoku Pharma Product

Table 95. Teikoku Pharma Recent Development

Table 96. Mylan Corporation Information

Table 97. Mylan Description and Major Businesses

Table 98. Mylan Transdermal Skin Patch Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 99. Mylan Product

Table 100. Mylan Recent Development

Table 101. Actavis Corporation Information

Table 102. Actavis Description and Major Businesses

Table 103. Actavis Transdermal Skin Patch Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 104. Actavis Product

Table 105. Actavis Recent Development

Table 106. Mundipharma Corporation Information

Table 107. Mundipharma Description and Major Businesses

Table 108. Mundipharma Transdermal Skin Patch Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 109. Mundipharma Product

Table 110. Mundipharma Recent Development

Table 111. Henan Lingrui Pharmaceutical Corporation Information

Table 112. Henan Lingrui Pharmaceutical Description and Major Businesses

Table 113. Henan Lingrui Pharmaceutical Transdermal Skin Patch Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 114. Henan Lingrui Pharmaceutical Product

Table 115. Henan Lingrui Pharmaceutical Recent Development

Table 116. Changzhou Siyao Corporation Information

Table 117. Changzhou Siyao Description and Major Businesses

Table 118. Changzhou Siyao Transdermal Skin Patch Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 119. Changzhou Siyao Product

Table 120. Changzhou Siyao Recent Development

Table 121. Rfl Pharmaceutical Corporation Information

Table 122. Rfl Pharmaceutical Description and Major Businesses

Table 123. Rfl Pharmaceutical Transdermal Skin Patch Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 124. Rfl Pharmaceutical Product

Table 125. Rfl Pharmaceutical Recent Development

Table 126. Luye Pharma Group Ltd. Corporation Information

Table 127. Luye Pharma Group Ltd. Description and Major Businesses

Table 128. Luye Pharma Group Ltd. Transdermal Skin Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 129. Luye Pharma Group Ltd. Product

Table 130. Luye Pharma Group Ltd. Recent Development

Table 131. Purdue Pharma L.P. Corporation Information

Table 132. Purdue Pharma L.P. Description and Major Businesses

Table 133. Purdue Pharma L.P. Transdermal Skin Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 134. Purdue Pharma L.P. Product

Table 135. Purdue Pharma L.P. Recent Development

Table 136. Teva Pharmaceutical Industries Ltd. Corporation Information

Table 137. Teva Pharmaceutical Industries Ltd. Description and Major Businesses

Table 138. Teva Pharmaceutical Industries Ltd. Transdermal Skin Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 139. Teva Pharmaceutical Industries Ltd. Product

Table 140. Teva Pharmaceutical Industries Ltd. Recent Development

Table 141. Global Transdermal Skin Patch Sales Forecast by Regions (2021-2026) (K Units)

Table 142. Global Transdermal Skin Patch Sales Market Share Forecast by Regions (2021-2026)

Table 143. Global Transdermal Skin Patch Revenue Forecast by Regions (2021-2026) (US$ Million)

Table 144. Global Transdermal Skin Patch Revenue Market Share Forecast by Regions (2021-2026)

Table 145. North America: Transdermal Skin Patch Sales Forecast by Country (2021-2026) (K Units)

Table 146. North America: Transdermal Skin Patch Revenue Forecast by Country (2021-2026) (US$ Million)

Table 147. Europe: Transdermal Skin Patch Sales Forecast by Country (2021-2026) (K Units)

Table 148. Europe: Transdermal Skin Patch Revenue Forecast by Country (2021-2026) (US$ Million)

Table 149. Asia Pacific: Transdermal Skin Patch Sales Forecast by Region (2021-2026) (K Units)

Table 150. Asia Pacific: Transdermal Skin Patch Revenue Forecast by Region (2021-2026) (US$ Million)

Table 151. Latin America: Transdermal Skin Patch Sales Forecast by Country (2021-2026) (K Units)

Table 152. Latin America: Transdermal Skin Patch Revenue Forecast by Country (2021-2026) (US$ Million)

Table 153. Middle East and Africa: Transdermal Skin Patch Sales Forecast by Country (2021-2026) (K Units)

Table 154. Middle East and Africa: Transdermal Skin Patch Revenue Forecast by Country (2021-2026) (US$ Million)

Table 155. Key Opportunities and Drivers: Impact Analysis (2021-2026)

Table 156. Key Challenges

Table 157. Market Risks

Table 158. Main Points Interviewed from Key Transdermal Skin Patch Players

Table 159. Transdermal Skin Patch Customers List

Table 160. Transdermal Skin Patch Distributors List

Table 161. Research Programs/Design for This Report

Table 162. Key Data Information from Secondary Sources

Table 163. Key Data Information from Primary Sources

List of Figures

Figure 1. Transdermal Skin Patch Product Picture

Figure 2. Global Transdermal Skin Patch Sales Market Share by Type in 2020 & 2026

Figure 3. Fentanyl Transdermal Skin Patch Product Picture

Figure 4. Nicotine Transdermal Skin Patch Product Picture

Figure 5. Clonidine Transdermal Skin Patch Product Picture

Figure 6. Buprenorphine Transdermal Skin Patch Product Picture

Figure 7. Global Transdermal Skin Patch Sales Market Share by Application in 2020 & 2026

Figure 8. Relieve Severe Pain

Figure 9. Stop Smoking Cigarettes

Figure 10. Treat An Overactive Bladder

Figure 11. Others

Figure 12. Transdermal Skin Patch Report Years Considered

Figure 13. Global Transdermal Skin Patch Market Size 2015-2026 (US$ Million)

Figure 14. Global Transdermal Skin Patch Sales 2015-2026 (K Units)

Figure 15. Global Transdermal Skin Patch Market Size Market Share by Region: 2020 Versus 2026

Figure 16. Global Transdermal Skin Patch Sales Market Share by Region (2015-2020)

Figure 17. Global Transdermal Skin Patch Sales Market Share by Region in 2019

Figure 18. Global Transdermal Skin Patch Revenue Market Share by Region (2015-2020)

Figure 19. Global Transdermal Skin Patch Revenue Market Share by Region in 2019

Figure 20. Global Transdermal Skin Patch Sales Share by Manufacturer in 2019

Figure 21. The Top 10 and 5 Players Market Share by Transdermal Skin Patch Revenue in 2019

Figure 22. Transdermal Skin Patch Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019

Figure 23. Global Transdermal Skin Patch Sales Market Share by Type (2015-2020)

Figure 24. Global Transdermal Skin Patch Sales Market Share by Type in 2019

Figure 25. Global Transdermal Skin Patch Revenue Market Share by Type (2015-2020)

Figure 26. Global Transdermal Skin Patch Revenue Market Share by Type in 2019

Figure 27. Global Transdermal Skin Patch Market Share by Price Range (2015-2020)

Figure 28. Global Transdermal Skin Patch Sales Market Share by Application (2015-2020)

Figure 29. Global Transdermal Skin Patch Sales Market Share by Application in 2019

Figure 30. Global Transdermal Skin Patch Revenue Market Share by Application (2015-2020)

Figure 31. Global Transdermal Skin Patch Revenue Market Share by Application in 2019

Figure 32. North America Transdermal Skin Patch Sales Growth Rate 2015-2020 (K Units)

Figure 33. North America Transdermal Skin Patch Revenue Growth Rate 2015-2020 (US$ Million)

Figure 34. North America Transdermal Skin Patch Sales Market Share by Country in 2019

Figure 35. North America Transdermal Skin Patch Revenue Market Share by Country in 2019

Figure 36. U.S. Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)

Figure 37. U.S. Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)

Figure 38. Canada Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)

Figure 39. Canada Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)

Figure 40. North America Transdermal Skin Patch Market Share by Type in 2019

Figure 41. North America Transdermal Skin Patch Market Share by Application in 2019

Figure 42. Europe Transdermal Skin Patch Sales Growth Rate 2015-2020 (K Units)

Figure 43. Europe Transdermal Skin Patch Revenue Growth Rate 2015-2020 (US$ Million)

Figure 44. Europe Transdermal Skin Patch Sales Market Share by Country in 2019

Figure 45. Europe Transdermal Skin Patch Revenue Market Share by Country in 2019

Figure 46. Germany Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)

Figure 47. Germany Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)

Figure 48. France Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)

Figure 49. France Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)

Figure 50. U.K. Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)

Figure 51. U.K. Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)

Figure 52. Italy Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)

Figure 53. Italy Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)

Figure 54. Russia Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)

Figure 55. Russia Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)

Figure 56. Europe Transdermal Skin Patch Market Share by Type in 2019

Figure 57. Europe Transdermal Skin Patch Market Share by Application in 2019

Figure 58. Asia Pacific Transdermal Skin Patch Sales Growth Rate 2015-2020 (K Units)

Figure 59. Asia Pacific Transdermal Skin Patch Revenue Growth Rate 2015-2020 (US$ Million)

Figure 60. Asia Pacific Transdermal Skin Patch Sales Market Share by Region in 2019

Figure 61. Asia Pacific Transdermal Skin Patch Revenue Market Share by Region in 2019

Figure 62. China Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)

Figure 63. China Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)

Figure 64. Japan Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)

Figure 65. Japan Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)

Figure 66. South Korea Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)

Figure 67. South Korea Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)

Figure 68. India Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)

Figure 69. India Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)

Figure 70. Australia Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)

Figure 71. Australia Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)

Figure 72. Taiwan Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)

Figure 73. Taiwan Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)

Figure 74. Indonesia Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)

Figure 75. Indonesia Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)

Figure 76. Thailand Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)

Figure 77. Thailand Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)

Figure 78. Malaysia Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)

Figure 79. Malaysia Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)

Figure 80. Philippines Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)

Figure 81. Philippines Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)

Figure 82. Vietnam Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)

Figure 83. Vietnam Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)

Figure 84. Asia Pacific Transdermal Skin Patch Market Share by Type in 2019

Figure 85. Asia Pacific Transdermal Skin Patch Market Share by Application in 2019

Figure 86. Latin America Transdermal Skin Patch Sales Growth Rate 2015-2020 (K Units)

Figure 87. Latin America Transdermal Skin Patch Revenue Growth Rate 2015-2020 (US$ Million)

Figure 88. Latin America Transdermal Skin Patch Sales Market Share by Country in 2019

Figure 89. Latin America Transdermal Skin Patch Revenue Market Share by Country in 2019

Figure 90. Mexico Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)

Figure 91. Mexico Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)

Figure 92. Brazil Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)

Figure 93. Brazil Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)

Figure 94. Argentina Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)

Figure 95. Argentina Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)

Figure 96. Latin America Transdermal Skin Patch Market Share by Type in 2019

Figure 97. Latin America Transdermal Skin Patch Market Share by Application in 2019

Figure 98. Middle East and Africa Transdermal Skin Patch Sales Growth Rate 2015-2020 (K Units)

Figure 99. Middle East and Africa Transdermal Skin Patch Revenue Growth Rate 2015-2020 (US$ Million)

Figure 100. Middle East and Africa Transdermal Skin Patch Sales Market Share by Country in 2019

Figure 101. Middle East and Africa Transdermal Skin Patch Revenue Market Share by Country in 2019

Figure 102. Turkey Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)

Figure 103. Turkey Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)

Figure 104. Saudi Arabia Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)

Figure 105. Saudi Arabia Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)

Figure 106. U.A.E Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)

Figure 107. U.A.E Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)

Figure 108. Middle East and Africa Transdermal Skin Patch Market Share by Type in 2019

Figure 109. Middle East and Africa Transdermal Skin Patch Market Share by Application in 2019

Figure 110. Hisamitsu Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018

Figure 111. Novartis Total Revenue (US$ Million): 2019 Compared with 2018

Figure 112. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018

Figure 113. Teikoku Pharma Total Revenue (US$ Million): 2019 Compared with 2018

Figure 114. Mylan Total Revenue (US$ Million): 2019 Compared with 2018

Figure 115. Actavis Total Revenue (US$ Million): 2019 Compared with 2018

Figure 116. Mundipharma Total Revenue (US$ Million): 2019 Compared with 2018

Figure 117. Henan Lingrui Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018

Figure 118. Changzhou Siyao Total Revenue (US$ Million): 2019 Compared with 2018

Figure 119. Rfl Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018

Figure 120. Luye Pharma Group Ltd. Total Revenue (US$ Million): 2019 Compared with 2018

Figure 121. Purdue Pharma L.P. Total Revenue (US$ Million): 2019 Compared with 2018

Figure 122. Teva Pharmaceutical Industries Ltd. Total Revenue (US$ Million): 2019 Compared with 2018

Figure 123. North America Transdermal Skin Patch Sales Growth Rate Forecast (2021-2026) (K Units)

Figure 124. North America Transdermal Skin Patch Revenue Growth Rate Forecast (2021-2026) (US$ Million)

Figure 125. Europe Transdermal Skin Patch Sales Growth Rate Forecast (2021-2026) (K Units)

Figure 126. Europe Transdermal Skin Patch Revenue Growth Rate Forecast (2021-2026) (US$ Million)

Figure 127. Asia Pacific Transdermal Skin Patch Sales Growth Rate Forecast (2021-2026) (K Units)

Figure 128. Asia Pacific Transdermal Skin Patch Revenue Growth Rate Forecast (2021-2026) (US$ Million)

Figure 129. Latin America Transdermal Skin Patch Sales Growth Rate Forecast (2021-2026) (K Units)

Figure 130. Latin America Transdermal Skin Patch Revenue Growth Rate Forecast (2021-2026) (US$ Million)

Figure 131. Middle East and Africa Transdermal Skin Patch Sales Growth Rate Forecast (2021-2026) (K Units)

Figure 132. Middle East and Africa Transdermal Skin Patch Revenue Growth Rate Forecast (2021-2026) (US$ Million)

Figure 133. Porter's Five Forces Analysis

Figure 134. Channels of Distribution

Figure 135. Distributors Profiles

Figure 136. Bottom-up and Top-down Approaches for This Report

Figure 137. Data Triangulation

Figure 138. Key Executives Interviewed

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

2020 World Blood Typing, Grouping and Infectious Disease NAT Screening Market in 68 Countries: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for over 40 Tests, Technology and Instrumentation Review

This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.

The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...

  • Publish Date: March 2, 2020
  • $0
Hearing Aids Market in India 2011

Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...

  • Publish Date: March 10, 2011
  • $950
Cardiac Pacemaker Market in India 2011

The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...

  • Publish Date: July 18, 2011
  • $950